About PharmaCielo
PharmaCielo is a company based in Toronto (Canada) founded in 2014.. PharmaCielo has raised $16.44 million across 10 funding rounds. PharmaCielo has completed 2 acquisitions, including Creso Pharma and Ubiquo Telemedicina. PharmaCielo offers products and services including CBD Isolate, Medicinal Flower, and Cannabis Extracts. PharmaCielo operates in a competitive market with competitors including Canopy Growth, Organigram, Cannara Biotech, C21 Investments and Aphria, among others.
- Headquarter Toronto, Canada
- Stage Public
-
Sectors
Agriculture
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pharmacielo Ltd.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$16.44 M (USD)
in 10 rounds
-
Latest Funding Round
$10 M (USD), Post-IPO
Nov 03, 2020
-
Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
Creso Pharma
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of PharmaCielo
PharmaCielo is a publicly listed company on the OTC with ticker symbol PCLOF in USA, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of PharmaCielo
PharmaCielo offers a comprehensive portfolio of products and services, including CBD Isolate, Medicinal Flower, and Cannabis Extracts. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Pure CBD refined for precise medicinal and pharmaceutical applications.
High-quality cannabis flower grown for reliable pharmaceutical use.
Processed extracts for consistent, safe medicinal applications.
Unlock access to complete
Funding Insights of PharmaCielo
PharmaCielo has successfully raised a total of $16.44M across 10 strategic funding rounds. The most recent funding activity was a Post-IPO round of $10 million completed in November 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Post-IPO — $10.0M
-
First Round
First Round
(12 May 2015)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2020 | Amount | Post-IPO - PharmaCielo | Valuation |
investors |
|
| Apr, 2020 | Amount | Post-IPO - PharmaCielo | Valuation |
investors |
|
| Feb, 2019 | Amount | Post-IPO - PharmaCielo | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by PharmaCielo
PharmaCielo has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Creso Pharma and Ubiquo Telemedicina. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cannabinoid therapeutics are developed for human and veterinary health applications.
|
2015 | ||||
|
Web platforms for telemedicine, workflow, and image management are provided.
|
2010 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - PharmaCielo
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pharmacielo Comparisons
Competitors of PharmaCielo
PharmaCielo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Canopy Growth, Organigram, Cannara Biotech, C21 Investments and Aphria, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cannabis products are provided to support consumer wellness and health.
|
|
| domain | founded_year | HQ Location |
Provider of cannabis products, brands, and international business development investments
|
|
| domain | founded_year | HQ Location |
Medicinal cannabis cultivation facility
|
|
| domain | founded_year | HQ Location |
Cannabis and hemp-derived products are cultivated, processed, and supplied.
|
|
| domain | founded_year | HQ Location |
Cannabis-derived nutritional and wellness products are provided by Aphria.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pharmacielo
Frequently Asked Questions about PharmaCielo
When was PharmaCielo founded?
PharmaCielo was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is PharmaCielo located?
PharmaCielo is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Who is the current CEO of PharmaCielo?
Marc Lustig is the current CEO of PharmaCielo.
Is PharmaCielo a funded company?
PharmaCielo is a funded company, having raised a total of $16.44M across 10 funding rounds to date. The company's 1st funding round was a Post-IPO of $6.32M, raised on May 12, 2015.
What does PharmaCielo do?
PharmaCielo was founded in 2014 and is headquartered in Toronto, Canada. Operations focus on the cultivation and marketing of medicinal cannabis in Colombia, where proprietary strains are grown under controlled indoor environments. Cannabis flowers are processed to extract oil and manufacture pharmaceutical-grade products for the health sector.
Who are the top competitors of PharmaCielo?
PharmaCielo's top competitors include Canopy Growth, Organigram and Cannara Biotech.
What products or services does PharmaCielo offer?
PharmaCielo offers CBD Isolate, Medicinal Flower, and Cannabis Extracts.
Is PharmaCielo publicly traded?
Yes, PharmaCielo is publicly traded on OTC under the ticker symbol PCLOF.
How many acquisitions has PharmaCielo made?
PharmaCielo has made 2 acquisitions, including Creso Pharma, and Ubiquo Telemedicina.
What is PharmaCielo's ticker symbol?
The ticker symbol of PharmaCielo is PCLOF on OTC.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.